All Stories

  1. Direct Inference of Haplotypes from Sequencing Data
  2. Optimizing Xenium In Situ data utility by quality assessment and best-practice analysis workflows
  3. Imaging flow cytometry with a real-time throughput beyond 1,000,000 events per second
  4. MRRM: Advanced Biomarker Alignment in Multi-Staining Pathology Images via Multi-Scale Ring Rotation-Invariant Matching
  5. BVSim: A benchmarking variation simulator mimicking human variation spectrum
  6. Parallel Analyses by Mass Spectrometry (MS) and Reverse Phase Protein Array (RPPA) Reveal Complementary Proteomic Profiles in Triple‐Negative Breast Cancer (TNBC) Patient Tissues and Cell Cultures
  7. cascAGS: Comparative Analysis of SNP Calling Methods for Human Genome Data in the Absence of Gold Standard
  8. CellSAM: Advancing Pathologic Image Cell Segmentation via Asymmetric Large‐Scale Vision Model Feature Distillation Aggregation Network
  9. Proteomics Landscape of Triple-Negative Apocrine Breast Carcinoma Reveals Molecular Mechanisms of Tumorigenesis and Characteristics of Chemo-insensitivity
  10. Bridging Discoveries and Treatments: The New Landscape of Breast Cancer Research
  11. Parallel Analyses by Mass Spectrometry (MS) and Reverse Phase Protein Array (RPPA) Reveal Complementary Proteomic Profiles in Triple-Negative Breast Cancer (TNBC) Patient Tissues and Cell Cultures
  12. MSGM: An Advanced Deep Multi-Size Guiding Matching Network for Whole Slide Histopathology Images Addressing Staining Variation and Low Visibility Challenges
  13. Loss of Human Epidermal Receptor 2 Expression in Formalin-Fixed Paraffin-Embedded Breast Cancer Samples and the Rescuing Effect of Enhanced Antigen Retrieval and Signal Amplification
  14. An orientation-free ring feature descriptor with stain-variability normalization for pathology image matching
  15. Author Correction: The landscape of viral associations in human cancers
  16. Author Correction: Butler enables rapid cloud-based analysis of thousands of human genomes
  17. Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
  18. Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
  19. Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
  20. Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
  21. Author Correction: Pan-cancer analysis of whole genomes
  22. Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
  23. Author Correction: Genomic basis for RNA alterations in cancer
  24. Author Correction: Patterns of somatic structural variation in human cancer genomes
  25. Author Correction: The evolutionary history of 2,658 cancers
  26. Author Correction: The repertoire of mutational signatures in human cancer
  27. Biomarker Alteration after Neoadjuvant Endocrine Therapy or Chemotherapy in Estrogen Receptor-Positive Breast Cancer
  28. Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
  29. Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower
  30. Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours
  31. Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer
  32. Author Correction: Inferring structural variant cancer cell fraction
  33. Author Correction: Integrative pathway enrichment analysis of multivariate omics data
  34. Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes
  35. Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
  36. Author Correction: High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
  37. Author Correction: Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis
  38. Adverse Events of PD-1 or PD-L1 Inhibitors in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
  39. Survival in Breast Cancer Patients with Bone Metastasis: A Multicenter Real-World Study on the Prognostic Impact of Intensive Postoperative Bone Scan after Initial Diagnosis of Breast Cancer (CSBrS-023)
  40. Assessment of accuracy in identifying structural variants using third-generation sequencing for breast cancer in the absence of gold standard
  41. AR Expression Correlates with Distinctive Clinicopathological and Genomic Features in Breast Cancer Regardless of ESR1 Expression Status
  42. Germline Variants in 32 Cancer-Related Genes among 700 Chinese Breast Cancer Patients by Next-Generation Sequencing: A Clinic-Based, Observational Study
  43. Two-Dose Vaccination Significantly Prolongs the Duration from Symptom Onset to Death: A Retrospective Study Based on 173,894 SARS-CoV-2 Cases in Khyber Pakhtunkhwa, Pakistan
  44. Tunable mechanical and degradation properties of biodegradable Mg-Y-Zn alloys via Zn content regulation
  45. HER2-low-positive features a distinct subtype in estrogen receptor-positive breast cancer associated with endocrine therapy resistance
  46. Expression of DNA Helicase Genes Was Correlated with Homologous Recombination Deficiency in Breast Cancer
  47. BM-Net: CNN-Based MobileNet-V3 and Bilinear Structure for Breast Cancer Detection in Whole Slide Images
  48. Androgen receptor expression associates with distinctive clinicopathological and molecular features in ER-positive and ER-negative breast cancer
  49. Intraparenchymal breast leiomyoma and atypical leiomyoma
  50. Detection of Structural Variations and Fusion Genes in Breast Cancer Samples Using Third-Generation Sequencing
  51. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
  52. Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy
  53. The natural history of breast cancer: a chronological analysis of breast cancer progression using data from the SEER database
  54. Triple negative apocrine breast carcinoma has better prognosis despite poor response to neoadjuvant chemotherapy
  55. Modeling effective tumor burden of primary lesion and metastatic lymph node in breast cancer patients from the SEER database
  56. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
  57. Detection of structural variations and fusion genes in breast cancer samples using third-generation sequencing
  58. Identification and Functional Characterization of a Novel Nonsense Variant in ARR3 in a Southern Chinese Family With High Myopia
  59. Androgen Receptor Expression Associates With Distinctive Clinicopathological and Molecular Features in ER-Positive and ER-Negative Breast Cancer
  60. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
  61. Androgen Receptor Expression Associates With Distinctive Clinicopathological and Molecular Features in ER-Positive and ER-Negative Breast Cancer
  62. Detection of structural variations and fusion genes in breast cancer samples using third-generation sequencing
  63. Intraparenchymal Breast Leiomyoma and Atypical Leiomyoma
  64. Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scores
  65. Prognosis classification of breast cancer with distant lymph node metastasis IIIc or M1 category
  66. Evaluating and Balancing the Risk of Breast Cancer-Specific Death and Other Cause-Specific Death in Elderly Breast Cancer Patients
  67. A Histone Acetylation Modulator Gene Signature for Classification and Prognosis of Breast Cancer
  68. Mechanism and effect of stress granule formation in cancer and its potential roles in breast cancer therapy
  69. Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China
  70. RECQL5 KIX domain splicing isoforms have distinct functions in transcription repression and DNA damage response
  71. A Machine Learning Approach to Differentiate Two Specific Breast Cancer Subtypes Using Androgen Receptor Pathway Genes
  72. Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
  73. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
  74. Sex differences in oncogenic mutational processes
  75. Highly Recurrent Copy Number Variations in GABRB2 Associated With Schizophrenia and Premenstrual Dysphoric Disorder
  76. Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
  77. Publisher Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
  78. Detecting viruses in tumour tissue to discover links between cancer and infection
  79. Inferring structural variant cancer cell fraction
  80. Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
  81. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
  82. Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis
  83. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
  84. Combined burden and functional impact tests for cancer driver discovery using DriverPower
  85. Divergent mutational processes distinguish hypoxic and normoxic tumours
  86. Genomic footprints of activated telomere maintenance mechanisms in cancer
  87. High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
  88. Integrative pathway enrichment analysis of multivariate omics data
  89. Pathway and network analysis of more than 2500 whole cancer genomes
  90. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
  91. Comprehensive molecular characterization of mitochondrial genomes in human cancers
  92. Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
  93. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
  94. Butler enables rapid cloud-based analysis of thousands of human genomes
  95. Genomic basis for RNA alterations in cancer
  96. Patterns of somatic structural variation in human cancer genomes
  97. The repertoire of mutational signatures in human cancer
  98. Pan-cancer analysis of whole genomes
  99. The evolutionary history of 2,658 cancers
  100. Genomic subtyping of liver cancers with prognostic application
  101. Natural History of Breast Cancer: Reanalyze Nodal Stage and Oestrogen Receptor Status Affecting the Progression of Breast Cancer from SEER Database
  102. Transcriptional regulation of Bcl-2 gene by the PR/SET domain family member PRDM10
  103. Characteristics and Prognostic Factors of Patients With Osteosarcoma Older Than 60 Years From the SEER Database
  104. AluScanCNV2: An R package for copy number variation calling and cancer risk prediction with next-generation sequencing data
  105. Forward and reverse mutations in stages of cancer development
  106. Forward-reverse mutation cycles between stages of cancer development
  107. Coevolution Theory of the Genetic Code at Age Forty: Pathway to Translation and Synthetic Life
  108. Tripartite genome of all species
  109. Feature co-localization landscape of the human genome
  110. GABRB2 Haplotype Association with Heroin Dependence in Chinese Population
  111. Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response
  112. The genetic equidistance result: misreading by the molecular clock and neutral theory and reinterpretation nearly half of a century later